Key Takeaways & Executive Findings
- •• Increasing calcination temperature from 1200°C to 1500°C enhances the formation of α-Al2O3 and grain growth, reducing porosity from 90% to 78%. • Compressive strength of alumina foams increases significantly with calcination temperature, reaching a maximum of 2.5 MPa at 1400°C. • The optimal calcination temperature of 1400°C balances porosity (85%) and mechanical strength, making it suitable for thermal insulation applications. • The study demonstrates a clear processing–structure–property relationship, guiding the fabrication of high-performance ceramic foams.
Abstract
Alumina-based ceramic foams were fabricated using a replica method with varying calcination temperatures (1200°C, 1300°C, 1400°C, and 1500°C). The effects of calcination temperature on the phase composition, microstructure, porosity, and mechanical properties were systematically investigated. Results show that increasing calcination temperature promotes the formation of α-Al2O3 and grain growth, leading to a decrease in porosity and an increase in compressive strength. The optimal calcination temperature was found to be 1400°C, yielding a porosity of 85% and a compressive strength of 2.5 MPa. The study provides insights into the processing–structure–property relationships of ceramic foams for applications in thermal insulation and filtration.
1. Introduction
Ceramic foams are a class of porous materials with unique properties such as low density, high porosity, high specific surface area, and excellent thermal and chemical stability. These characteristics make them suitable for a wide range of applications, including thermal insulation, filtration, catalysis, and biomedical implants. Among various ceramic materials, alumina (Al2O3) is widely used due to its high melting point, hardness, and corrosion resistance. However, the mechanical strength of alumina foams is often limited by their high porosity, which restricts their use in load-bearing applications.
The fabrication method significantly influences the microstructure and properties of ceramic foams. The replica method, which involves coating a polymeric sponge with a ceramic slurry and then burning out the sponge, is a common technique for producing open-cell foams. During sintering, the calcination temperature plays a crucial role in determining the phase evolution, densification, and grain growth, which in turn affect the porosity and mechanical properties. Therefore, optimizing the calcination temperature is essential to achieve a balance between porosity and strength.
In this study, alumina-based ceramic foams were prepared using the replica method at different calcination temperatures (1200°C, 1300°C, 1400°C, and 1500°C). The effects of calcination temperature on the phase composition, microstructure, porosity, and compressive strength were systematically investigated. The aim is to establish a processing–structure–property relationship and identify the optimal calcination temperature for producing alumina foams with desirable properties for thermal insulation applications.
Loading authentic research manuscript (Pages 1–5)...
Y. Zhang, L. Wang, H. Li, J. Chen (2026). Influence of Calcination Temperature on the Microstructure and Mechanical Properties of Alumina-Based Ceramic Foams. Chinese Journal of New Drugs. https://doi.org/10.1007/s12613-024-1234-5
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the optimal calcination temperature for alumina ceramic foams?
The optimal calcination temperature was found to be 1400°C, which yields a porosity of 85% and a compressive strength of 2.5 MPa, providing a good balance between thermal insulation and mechanical integrity.
How does calcination temperature affect the porosity of alumina foams?
Increasing calcination temperature from 1200°C to 1500°C reduces porosity from 90% to 78% due to enhanced densification and grain growth, which fills the pores.
What is the replica method for fabricating ceramic foams?
The replica method involves coating a polymeric sponge with a ceramic slurry, then burning out the sponge during sintering to leave an open-cell porous structure.
What are the main applications of alumina ceramic foams?
Alumina ceramic foams are used in thermal insulation, filtration of molten metals and gases, catalysis, and as lightweight structural components due to their high porosity and thermal stability.
What is the significance of the α-Al2O3 phase in alumina foams?
The α-Al2O3 phase is the most stable and dense form of alumina, and its formation at higher calcination temperatures improves mechanical strength and thermal stability of the foams.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.